Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Corvus Pharmaceuticals, Inc. (CRVS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
0.8640+0.0117 (+1.37%)
At close: 03:57PM EST
0.8688 +0.00 (+0.56%)
After hours: 04:58PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
MACD

MACD

Previous Close0.8523
Open0.8687
Bid0.8411 x 900
Ask0.8688 x 800
Day's Range0.8202 - 0.8687
52 Week Range0.6950 - 2.1700
Volume47,001
Avg. Volume135,950
Market Cap40.222M
Beta (5Y Monthly)1.04
PE Ratio (TTM)N/A
EPS (TTM)-0.8910
Earnings DateMar 08, 2023 - Mar 13, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.83
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for CRVS

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Corvus Pharmaceuticals, Inc.
    Daily – Vickers Top Buyers & Sellers for 05/06/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    2 years agoArgus Research
View more
Advertisement
Advertisement